Sign up for a new account.
And get access to
The latest T1D content
Research that matters
Our daily questions
Sign up by entering your info below.
Reset Your Password
We will email you instructions to reset your
Inequities in health care delivery and outcomes continue to exist in the field of medicine, despite increased awareness of racial and ethnic inequities. To inform future research on the barriers to care and potential interventions to improve diabetes care for individuals from all backgrounds, it is important to use large cohorts to identify these disparities. T1D Exchange QI (T1DX-QI) is a population-based cohort with twelve national clinics engaged in data sharing and quality improvement (QI) methods to drive system changes. Over 22,000 pediatric and adult patient demographic and diabetes characteristics data were combined and analyzed from seven T1DX-QI clinics. Characteristics of the patient population are available in Table 1. The cohort included 75% non-Hispanic White (NHW), 7% non-Hispanic Black (NHB), 3% Hispanic and 15% Other. Mean A1C was highest in NHB (9.9%) and Hispanic (9.3%; p<0.001) participants. Insulin pump and continuous glucose monitor use was lowest in NHB participants (p<0.001). The T1DX-QI cohort is the largest population to date available to investigate health inequities in T1D. Differences in A1C and technology use still persist, particularly in the NHB population. These results highlight the critical need to study barriers to care in individuals from various backgrounds in order to provide adequate and optimal care to everyone with T1D.
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Join our mailing list for more about T1D
- An Interview with Dr. Enrique Caballero: Providing Culturally-Oriented Care to the Latinx Communityby Taylor DennisOctober 14, 2021
- Dr. Osagie Ebekozien Awarded ISPAD’s Prize for Innovation in Pediatric Diabetes Careby Sarah TackettOctober 13, 2021
- T1D Exchange Research Highlights from ISPAD 2021by Sarah TackettOctober 13, 2021
- Status Update: Connected Insulin Delivery Devicesby Hope WarshawOctober 7, 2021
- Top Questions of the Day – September 2021by Sarah TackettSeptember 30, 2021